Page last updated: 2024-11-08

3,4-dihydro-3-hydroxy-8-methoxy-3-methyl-2h-benz(a)anthracene-1,7,12-trione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

MM 47755: from streptomycete isolated from soil; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID164046
MeSH IDM0166639

Synonyms (22)

Synonym
3,4-dihydro-3-hydroxy-8-methoxy-3-methyl-2h-benz(a)anthracene-1,7,12-trione
mm-47755
6-deoxy-8-o-methylrabelomycin
(-)-3,4-dihydro-3-hydroxy-8-methoxy-3-methylbenz(a)anthracene-1,7,12(2h)-trione
mm 47755
benz(a)anthracene-1,7,12(2h)-trione, 3,4-dihydro-3-hydroxy-8-methoxy-3-methyl-, (-)-
ACON1_001078
MEGXM0_000346
ACON0_001206
NCGC00169698-01
BRD-A22563582-001-01-2
117620-87-8
3-hydroxy-8-methoxy-3-methyl-3,4-dihydrotetraphene-1,7,12(2h)-trione
3-hydroxy-8-methoxy-3-methyl-2,4-dihydrobenzo[a]anthracene-1,7,12-trione
(r)-3-hydroxy-8-methoxy-3-methyl-3,4-dihydro-tetraphene-1,7,12(2h)-trione
HB3977
6-desoxy-8-o-methylrabelomycin
J-003641
DTXSID80922473
BS-1534
6-deoxy-8-o-methylrabelomycin; mm 47755
AKOS040736212
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]